1/117
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
hazardous drug
Drug that meets at least 1 of the following:
• Carcinogenic
• Teratogenic
• Fertility impairment
• Organ toxicity at low doses (
carcinogenic
cancer causing
teratogenic
causes congenital disabilities
genotoxicity
damages DNA, which can cause cancer
yes
Can exposure to hazardous drugs cause acute and long term AEs?
contaminated surfaces
What is the most common route of exposure with hazardous drugs?
skin, ocular, flu-like symptoms, HA
What are the acute reactions with exposure to hazardous drugs?
fetal abnormalities, loss of fertility, secondary cancers
What are the chronic reactions with exposure to hazardous drugs?
- Inhalation
- Accidental injection
- Ingestion of contaminated food or mouth contact with contaminated hands
- Dermal contact with contaminated surface
What are the routes of exposure with hazardous drugs?
non-chemo hazardous drugs
• Warfarin
• Fluconazole
• Isotretinoin
• Dronedarone
• Finasteride
• Paroxetine
• Phenytoin
• Colchicine
• Spironolactone
• Estrogens
• Progesterone
• Temazepam
• Cyclosporine
• Liraglutide
USP
provides regulatory standards for sterile compounding
USP 797
outlines sterile product preparation
USP 800
describes handling strategies for HD
ASHP
provides information on implementing recommendations and requirements for handling and compounding hazardous drugs
low risk hazardous drugs
-Limited risk of causing harm
-Counting and packaging tablets
-Do not require following all USP 800 requirements
-Safety Measures:
• Dedicated tray for counting
• Use of gloves
-Examples: finasteride, misoprostol
PIC
Who makes the rules on how you treat low risk hazardous drugs?
high risk hazardous drugs
• High risk of causing harm
• IV compounding; splitting tablets
• Must follow USP 800 requirements
• Example: IV chemotherapy
USP
Who makes the rules when handling high risk hazardous drugs?
-neg pressure room
-room externally vented
-a vertical flow biological safety cabinet
-appropriate air changes per hr
What is required per USP 800 in a compounding area?
at least 30 per hr in a room where the hood is located
What is the appropriate air change amount per hour in a compounding area per USP 800?
personal protective equipment per USP 800
- Double gloves or chemo rated gloves
- Impermeable gowns
- Double shoe covers
- Respiratory protection for spills/cleaning
• Dress from "dirtiest to cleanest"
- Exact order may differ between settings (shoes, hair, mask, gown, gloves)
Closed System Drug Transfer Device (CSTD)
-"a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system."
- Recommended to use throughout HD-handling chain from compounding to patient administration
negative
Hazardous drugs must be stored in a __________ pressure room.
segregate
You should __________ HD stock from other inventory.
must
Staff ______ wear gloves when handling HD inventory.
distinctive labels
Drug packages and storage areas must bear __________ for special handling precautions
PRONTO
Use of a standardized checklist can help reduce risk of error
patient
What does the P in PRONTO stand for?
regimen
What does the R in PRONTO stand for?
Organ system
What does the O in PRONTO stand for?
Numbers
What does the N in PRONTO stand for?
Toxicity
What does the T in PRONTO stand for?
Order verification
What does the O in PRONTO stand for?
Patient part in PRONTO
Review chart to gain an overview of the patient.
- What type of malignancy does the patient have?
- What is the goal of treatment? (curative vs palliative)
- What is the patient's performance status (ECOG score)?
- What type of line access does the patient have? (Central versus peripheral)
- What is the current treatment?
- What are current lab values?
ECOG 0
Fully active, able to carry on all pre-disease performance without restriction
ECOG 1
Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; e.g. light house work, office work
ECOG 2
Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours
ECOG 3
Capable of only limited self care, confined to bed or chair more than 50% of waking hours
ECOG 4
Completely disabled. Cannot carry on any self care. Totally confined to bed or chair
ECOG 5
dead
typically 0-2
What ECOG scores do we typically consider tx for?
typically 3-5
What ECOG scores do we typically consider comfort care for?
Regimen/dose part in PRONTO
Does the regimen match a published regimen and make sense for the patient?
- Do you have a reference that supports the regimen?
- Is the patient due for chemo based on cycle and day?
- Is the dosing of chemotherapy appropriate?
• Dose, route, dilution fluid, rate
- Is the sequencing of chemotherapy appropriate?
safety
What is the primary responsibility at the R-regimen/dose step in PRONTO?
drug information resources (Lexi, Micromedex)
these references are the least helpful with dosing regimens
cycle
how frequent the regimen is repeated
day
the day of each cycle the medication is given
1)vesicant -> irritant -> nonvesicant
2) efficacy/safety
3) stability
What is the sequencing of chemo?
less
The _____ stable agents of chemo should go first.
Organ function/labs part in PRONTO
Do the patient's organ function and labs warrant full dose treatment?
- CBC
- Electrolytes
- Renal Function (CrCl)
- Liver Function
- Urinalysis
- Echocardiogram/EKG
organ function/labs section to determine appropriate dosage adjustments and monitoring
When should you use drug info resources in PRONTO?
Numbers part in PRONTO
Dose Calculations
- CrCl
- BSA
- AUC
Admixture and Administration Numbers
- Concentrations
- Rate of Infusion
- Fluid type
BSA
estimate of cardiac output and distribution to the liver and kidneys and is commonly used for dosing in chemo
Carboplatin Dose (mg)= target AUC x (GFR + 25)
What is the Calvert Equation used for AUC dosing of Carboplatin?
Toxicities part in PRONTO
Does patient have appropriate medications to
prevent toxicities?
- Nausea/Vomiting?
- Infusion related reactions?
- Neutropenia?
- Tumor lysis syndrome?
Any risk of drug-drug interactions with other medications?
Order verification part in PRONTO
1. Independent Double Check of "PRONT" step
2. Compare chemotherapy order, label and product
Extravasation
The inadvertent instillation or leakage of a cytotoxic drug into the perivascular space during infusion
Irritant
• May induce a local inflammatory response
• Short-term injury; does not lead to tissue necrosis/injury
• Vein may be tender or have burning/erythema
• Blood return remains intact
Vesicant
• Severe necrosis; erythema and blistering of skin around extravasation
• May take up to 6-12 hrs for symptoms to appear
• Blood return is absent
• Anthracyclines, taxanes, vinca alkaloids
-use central catheter
-educate pt on s/s to report
-check for blood flow throughout admin
-bolus doses of irritant/vesicant chemo should be given over 5-10 mins through a free-flowing IV line
What are the ways to prevent extravasation?
pain, redness, swelling at injection site
What should the patient look out for to alert us that extravasation may be taking place?
extravasation tx
1. Stop infusion
2. Aspirate any drug via the intravenous cannula
3. Do NOT flush the line
4. Remove the catheter/needle
5. Elevate and immobilize the affected limb
6. Apply cold or warm packs as recommended (Warm: Vinca alkaloids; Cold- most everything else)
7. Administer antidote, if available
8. Photograph site and/or mark around area with permanent marker
9. Monitor site closely for 24 hrs and up to 2 weeks for redness, swelling, pain, ulceration, and/or necrosis
Dexrazoxane
-admin: IV infusion
-MOA: Prevent free-radical formation and reduce oxidative stress
-useful against Anthracyclines
Dimethyl sulfoxide (DMSO)
-admin: topical
-MOA: Neutralizes free radicals, promotes absorption of vesicant
-usedful against Anthracyclines, Cisplatin
Hyaluronidase
-admin: SC into infiltration site
-MOA: accelerates local connective tissue breakdown and absorption
-useful against Vinca or taxanes
Sodium thiosulfate
-admin: SC injection into infiltration site
-MOA: binds and neutralizes vesicant
-useful against Cisplatin
no
Are all tumors with (-omas) at the end malignant?
BSA
is believed to be a more accurate measure that eliminates"adipose" effects. Criticized for not taking into account inter-patient variation in pharmacokinetics and PGx.
-hormone therapy
-surgery
-bone marrow transplantation
-immunotherapy
-radiation therapy
-targeted therapy
-chemotherapy
What are the conventional tx options for cancer?
-surgery
-radiotherapy
-cytotoxic chemotherapy
-molecularly targeted therapy
-immunotherapy
What are the pillars of cancer care?
gene therapy
What will be the new and upcoming pillar of cancer care?
Neoadjuvant
Chemotherapy delivered BEFORE the main treatment, to help reduce the sizeof a tumor or kill cancer cells that have spread. In many cancers, its used to down stage select patients with malignant tumors, thereby rendering the primary tumors and metastases resectable in some cases
Adjuvant
Chemotherapy delivered AFTER primary treatment which attempts to eliminate micrometastasis; given to prevent a possible cancer recurrence
First line chemotherapy
Chemotherapy determined to have the best probability of treating a given cancer. This may also be called standard therapy.
Second line chemotherapy
Chemotherapy that is given if a disease has not responded or reoccurred after first line chemotherapy. In some cases, this may also be referred to as salvage therapy.
Palliative
Chemotherapy aimed at improving or managing symptoms
Curative
Elimination of all known tumor mass (Complete and Durable Response)
narrow
The therapeutic window for most cancer drugs is _________
wider
The ________ the therapeutic window the better.
therapeutic index
toxic dose/effective dose
safer
A therapeutic index of 3 or greater is a _______ drug.
adverse effects (off-target) of chemo
-alopecia
-mucositis
-pulmonary fibrosis
-N/V
-cardiotox
-Diarrhea
-Local reaction
-Cystitis
-Renal failure
-Sterility
-Myelosuppression
-Myalgia
-Neuropathy
-Phlebitis
• 5HT3 receptor antagonist (-setron class)
• Dexamethasone
• NK1 receptor antagonist (-pitant class)
Drug classes that treat CINV (nausea and vomiting)
no FDA approved therapies...yet (duloxetine)
Drug classes that treat CIPN (peripheral neuropathy)
bisphosphonates
Drug classes that treat bone loss (CIBL)
neutrophil enhancers
Drug classes that treat neutropenia (CIN) and febrile neutropenia (CIFN
platelet enhancers
Drug classes that treat thrombocytopenia (CIT)
erythropoietin stimulating agents (ESA)
Drug classes that treat anemia (CIA)
1) a therapy that targets
2) a population of cancer cells
3) a particular host environment
What is the 3 component system of cancer therapy?
intrinsic resistance
exists before drug tx
acquired resistance
is induced after therapy
50%
What % of cancer pts have drug resistance?
staging
describes the extent or spread of disease at the time of diagnosis
cancer extent and severity
What is staging in cancer used to gauge?
-summary
-TMN
What are the 2 staging systems generally used with cancer?
The Summary Staging System
more general of a system for staging
-in situ
-localized
-regional
-distant (metastatic)
What are the 4 main types of the summary staging system?
in situ
is early cancer that is present only in the layer of cells in which it began
localized
is cancer that is limited to the organ in which it began, without evidence of spread
regional
is cancer that has spread beyond the original (primary) site to nearby lymph nodes or organs and tissues